×

Sanofi CEO on Profit Pipeline

4:35 PM ET Thu, 12 April 2012

Sanofi CEO Christopher Viehbacher discusses his company's $20 billion acquisition of Genzyme and other opportunities he sees in the pharmaceutical market.